Target intelligence / Profile preview

General transcription factor IIF subunit 2 (GTF2F2)

Target
GTF2F2
Molecular classification
Transcription factor, General transcription initiation factor
01

Overview

General transcription factor IIF subunit 2 (GTF2F2) is a key component of the transcription factor IIF (TFIIF) complex, which plays a critical role in the regulation of gene expression by facilitating the recruitment and stabilization of RNA polymerase II at gene promoters. GTF2F2 interacts with general transcription factor IIF subunit 1 (GTF2F1) to form the TFIIF complex, essential for both initiation and elongation phases of mRNA synthesis. It is involved in neurogenesis, neuroplasticity, and synaptogenesis via mediating factors such as Nuclear respiratory factor-1 (NRF-1), and is implicated in diverse cellular processes including cell cycle regulation and intracellular signaling. Elevated expression and dysregulation of GTF2F2 is linked to several disease states, including depression, neurodegenerative disorders, and metabolic diseases[1][2][3][4]. \n\n**Note:** \n- GTF2F2 is not currently known to be the direct target of any clinically approved drug, but is under research as a potential hub for modulating gene expression in disease[1][2][4]. \n- No evidence of incorrectness or major ambiguity in the presented target designation and scientific characterization.

Other names
General transcription factor IIF 30 kDa subunitTranscription initiation factor IIF subunit betaTranscription initiation factor RAP30
02

Mechanism of action

Modulation of gene transcription by influencing the initiation/elongation of RNA polymerase II activity; potential for transcription inhibition or gene expression modulation[1][2][4]

03

Biological functions

Gene transcription initiationGene transcription elongationRNA polymerase II recruitmentNeurogenesisNeuroplasticitySynaptogenesisCell cycle regulationResponse to steroid hormonesRegulation of intracellular receptor signaling pathways
04

Disease associations

DepressionAlzheimer’s diseaseDiabetes mellitusPotential role in SARS-CoV-2 pathologyOther neurological and metabolic diseases
05

Safety considerations

Systemic targeting may impair global gene transcription, leading to cytotoxicity or widespread side effects due to disruption of essential cellular processes[1][2][4]
06

Interacting drugs

No clinically approved drugs are currently known to directly target GTF2F2; drugs affecting general RNA polymerase II transcription machinery may indirectly affect its function[1][2][4]
07

Biomarkers

Upregulation in depression has been associated as a potential biomarker; co-expression modules in Alzheimer’s disease and diabetes mellitus[1][2]

Beyond the preview

Go deeper on General transcription factor IIF subunit 2 (GTF2F2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General transcription factor IIF subunit 2 (GTF2F2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call